Essex Bio-Technology Ltd 01061
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 2.19
- Day Range
- HKD 2.19–2.30
- 52-Week Range
- HKD 1.96–3.80
- Bid/Ask
- HKD 2.20 / HKD 2.24
- Market Cap
- HKD 1.27 Bil
- Volume/Avg
- 230,000 / 140,706
Key Statistics
- Price/Earnings (Normalized)
- 4.63
- Price/Sales
- 0.78
- Dividend Yield (Trailing)
- 3.20%
- Dividend Yield (Forward)
- 4.11%
- Total Yield
- 4.21%
Company Profile
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People’s Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,481
- Website
- http://www.essexbio.com
Comparables
Valuation
Metric
|
01061
|
00867
|
06896
|
---|---|---|---|
Price/Earnings (Normalized) | 4.63 | 6.36 | — |
Price/Book Value | 0.67 | 1.01 | 1.80 |
Price/Sales | 0.78 | 1.95 | 2.12 |
Price/Cash Flow | 3.56 | 6.38 | 6.32 |
Price/Earnings
01061
00867
06896
Financial Strength
Metric
|
01061
|
00867
|
06896
|
---|---|---|---|
Quick Ratio | 1.42 | 3.91 | 2.37 |
Current Ratio | 1.54 | 4.29 | 2.78 |
Interest Coverage | 30.76 | 59.97 | 35.25 |
Quick Ratio
01061
00867
06896
Profitability
Metric
|
01061
|
00867
|
06896
|
---|---|---|---|
Return on Assets (Normalized) | 9.95% | 14.91% | 17.26% |
Return on Equity (Normalized) | 15.33% | 17.41% | 24.51% |
Return on Invested Capital (Normalized) | 12.40% | 15.18% | 19.65% |
Return on Assets
01061
00867
06896
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Vxvbhvdcx | Nyl | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Vcdhgpnclx | Xlhnm | $70.8 Bil | |
HLN
| Haleon PLC ADR | Nbbhhdbw | Hstwm | $38.2 Bil | |
VTRS
| Viatris Inc | Cjlclrnl | Wkvf | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Twwhmfcg | Gbx | $12.5 Bil | |
CTLT
| Catalent Inc | Ffyzpqqf | Ckckyx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Wdprzqqg | Jvv | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Gznxdfn | Tnps | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qzdwqqwt | Kkjxc | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Lgfdplxkp | Hccry | $2.9 Bil |